THROAT HPV TESTING FOR PATIENTS
OmniPathology’s Patent Pending Test

Revolutionary

HPV-related oropharyngeal (throat) cancer cases are at an all-time high. HPV is identified in at least 87% oropharyngeal cancers.

OmniPathology is proud to be a partner with many medical and dental providers in offering its proprietary, patent pending revolutionary new way to detect HPV using a throat swab.

  • Oral Sex

  • Multiple partners

  • Smoking

  • Excessive alcohol consumption

  • Open mouth kissing

  • Weak immune system

RISK FACTORS

FACTS:

  • HPV (human papillomavirus) is the most common sexually transmitted infection in the United States.

  • Oral and oropharyngeal HPV is often transmitted through oral sex.

  • Oral and oropharyngeal HPV have no symptons and most sexually active people will contract HPV at some point in their lifetime.

  • Most HPV infection resolves on its own, but persistent HPV infection is associated with cancer.

  • The number of people infected with oral and oropharyngeal HPV has increased over the past 30 years. According to the CDC, 10% of men and 3.6% of women have Oral HPV. Infections of HPV of the mouth and throat can cause 70% of oral cancers in the US, including oropharyngeal cancers.

  • Specimen collection is as easy as obtaining an oropharyngeal (throat) swab placed in viral transport media.

  • Patients who test positive for any of the high-risk types should be followed up and possibly retested in 6-12 to identify those with persistent HPV infection.

  • Follow up should also consider the patient's other risk factors and medical history.

FAQ’s:

Questions? Call us at (626) 744-5339 or email at info@omnipathology.com.
We are more than happy to speak with you!